Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Interpretations of Studies on SARS-CoV-2 Vaccination and Post-acute COVID-19 Sequelae.

Gonçalves BP. et al, (2024), Epidemiology, 35, 368 - 371

Diagnostic tests for human Schistosoma mansoni and Schistosoma haematobium infection: a systematic review and meta-analysis.

Vaillant MT. et al, (2024), Lancet Microbe, 5, e366 - e378

Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials

Chan XHS. et al, (2024)

Systematic Review of Scales for Measuring Infectious Disease-Related Stigma.

Paterson A. et al, (2024), Emerg Infect Dis, 30, 519 - 529

Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).

Pazukhina E. et al, (2024), BMC Med, 22

Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development

Castro MDM. et al, (2024), PLoS Neglected Tropical Diseases, 2024

Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development.

Castro MDM. et al, (2024), PLoS Negl Trop Dis, 18

Nipah virus disease: what can we do to improve patient care?

Hassan MZ. et al, (2024), Lancet Infectious Diseases

Experiences and challenges with the new European Clinical Trials Regulation.

Patrick-Brown TDJH. et al, (2024), Trials, 25

Challenges in Clinical Diagnosis of Clade I Mpox: Highlighting the Need for Enhanced Diagnostic Approaches

Bourner J. et al, (2024)

Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.

Bourner J. et al, (2024), PLoS One, 19

Mpox: The alarm went off. Have we gone back to sleep?

Olliaro P. et al, (2024), PLoS Negl Trop Dis, 18

Sex differences in post-acute neurological sequelae of SARS-CoV-2 and symptom resolution in adults after coronavirus disease 2019 hospitalization: an international multi-centre prospective observational study.

Cho S-M. et al, (2024), Brain Commun, 6

Bubonic plague: can the size of buboes be accurately and consistently measured with a digital calliper?

Bourner J. et al, (2023), Trials, 24

Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study.

Gorst SL. et al, (2023), Lancet Respir Med, 11, 1101 - 1114

Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.

Camirand-Lemyre F. et al, (2023), JAMA Netw Open, 6

A multi-country analysis of COVID-19 hospitalizations by vaccination status.

Gonçalves BP. et al, (2023), Med, 4, 797 - 812.e2

A systematic review of the clinical profile of patients with bubonic plague and the outcome measures used in research settings.

Bourner J. et al, (2023), PLoS Negl Trop Dis, 17

Long-Term Efficacy of Insecticidal Wall Painting for Controlling Visceral Leishmaniasis Vectors in Bangladesh.

Alim A. et al, (2023), Am J Trop Med Hyg, 109, 1022 - 1027

Variability in Clinical Assessment of Clade IIb mpox Lesions.

Jones B. et al, (2023), Int J Infect Dis

Load More

1
2
3
4
5

Include forthcoming?